EMPAGLIFLOZIN

Clinical Indication

Type 2 diabetes & Chronic Kidney Disease

Comments

Type 2 diabetes in line with NICE TA336. CKD treatment in line with NICE TA942. See local CKD pathway.

Date of classification

May 2015

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.